{"first_name":"Howard","last_name":"W. Robin","permalink":"howard-w-robin","crunchbase_url":"http://www.crunchbase.com/person/howard-w-robin","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Fri Jun 26 13:28:47 UTC 2009","updated_at":"Fri Jun 26 13:30:55 UTC 2009","overview":"<p>Howard W. Robin joined Nektar Therapeutics in January 2007. He has more than 25 years of successful biopharmaceutical experience managing clinical development and commercial operations. Most recently, Mr. Robin served as President and Chief Executive Officer of Sirna Therapeutics, a clinical-stage biotechnology company pioneering RNAi-based therapies for serious diseases and conditions, including age-related macular degeneration (AMD), hepatitis C, asthma, respiratory syncytial virus (RSV) and Huntington&#8217;s disease. </p>","image":{"available_sizes":[[[110,150],"assets/images/resized/0005/0893/50893v1-max-150x150.jpg"],[[121,164],"assets/images/resized/0005/0893/50893v1-max-250x250.jpg"],[[121,164],"assets/images/resized/0005/0893/50893v1-max-450x450.jpg"]],"attribution":""},"degrees":[{"degree_type":"B.S.","subject":"Accounting and Finance","institution":"Fairleigh Dickinson University","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"President and Chief Executive Officer","firm":{"name":"Nektar Therapeutics","permalink":"nektar-therapeutics","type_of_entity":"company","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/0890/50890v1-max-150x150.png"],[[220,80],"assets/images/resized/0005/0890/50890v1-max-250x250.png"],[[220,80],"assets/images/resized/0005/0890/50890v1-max-450x450.png"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}